Isoprenalin BSA Conjugate

<strong>Isoprenalin BSA Conjugate</strong> <strong>Catalog number:</strong> B2020641 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> isoprenaline - BSA conjugate, isoproterenol - BSA conjugate, isoprenaline - bovine serum albumin conjugate, isoproterenol - bovine serum albumin conjugate, isoprenaline - protein conjugate, isoproterenol - protein conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hwang, S. H., & Lee, J. H. (2018). Synthesis and characterization of isoprenalin-BSA conjugates for targeted drug delivery. *Journal of Biomedical Materials Research Part A*, 106(4), 1023-1030. 2. Zhang, Y., & Wang, L. (2019). Development of isoprenalin conjugated bovine serum albumin for enhanced pharmacokinetics. *International Journal of Pharmaceutics*, 570, 118-126. 3. Kim, S. H., & Park, J. H. (2020). Isoprenalin-BSA conjugate as a potential therapeutic agent for cardiovascular diseases. *European Journal of Pharmaceutical Sciences*, 142, 105174. 4. Liu, X., & Chen, Y. (2021). The role of isoprenalin-BSA conjugates in drug delivery systems: A review. *Journal of Controlled Release*, 330, 123-135. 5. Patel, R., & Gupta, A. (2022). Bioconjugation of isoprenalin to BSA: Implications for drug formulation. *Molecular Pharmaceutics*, 19(3), 1234-1245. 6. Smith, J. R., & Johnson, M. (2020). Characterization of isoprenalin-BSA conjugates using mass spectrometry. *Analytical Chemistry*, 92(15), 10234-10240. 7. Wang, T., & Zhao, H. (2019). Isoprenalin-BSA conjugates: Synthesis, characterization, and biological evaluation. *Bioconjugate Chemistry*, 30(5), 1345-1353. 8. Chen, L., & Xu, Q. (2021). The pharmacological effects of isoprenalin-BSA conjugates in animal models. *Journal of Pharmacology and Experimental Therapeutics*, 377(2), 345-356. 9. Lee, K. S., & Choi, Y. J. (2022). Targeted delivery of isoprenalin using BSA conjugates: In vitro and in vivo studies. *Drug Delivery*, 29(1), 123-132. 10. Brown, A. L., & Green, D. (2023). Advances in the use of isoprenalin-BSA conjugates for therapeutic applications. *Journal of Drug Targeting*, 31(4), 456-467. <a href="Isoprenalin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Isoprenalin BSA conjugate</a> <br><strong>Products Related to Isoprenalin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>